Three Cases of Unprovoked Venous Thromboembolism with Prothrombin p.Arg596Gln Variant and a Literature Review of Antithrombin Resistance.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Mar 2023
Historique:
pubmed: 10 8 2022
medline: 22 3 2023
entrez: 9 8 2022
Statut: ppublish

Résumé

Antithrombin resistance (ATR) is a newly identified strong genetic predisposition to venous thromboembolism (VTE) caused by genetic variations in prothrombin with substitutions of Arg at position 596 with either Leu, Gln, or Trp. In the present report, we identified a missense variant p.Arg596Gln in 3 patients from 2 families with unprovoked VTE who each experienced their first VTE event at 19, 67, and 19 years old. The three patients did not show any positive markers for thrombophilia on routine testing, suggesting that patients with unprovoked VTE who have negative findings on thrombophilia tests may carry a prothrombin variant with ATR.

Identifiants

pubmed: 35945029
doi: 10.2169/internalmedicine.9718-22
pmc: PMC10076131
doi:

Substances chimiques

Antithrombins 0
Prothrombin 9001-26-7
Antithrombin III 9000-94-6
Anticoagulants 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

885-888

Références

J Thromb Haemost. 2013 Oct;11(10):1936-9
pubmed: 23927452
Ann Hematol. 2016 Feb;95(3):541-2
pubmed: 26482463
J Clin Pathol. 2018 Jul;71(7):614-619
pubmed: 29331940
J Cardiol Cases. 2018 Mar 27;17(6):197-199
pubmed: 30279891
Arterioscler Thromb Vasc Biol. 2016 May;36(5):1022-9
pubmed: 27013614
N Engl J Med. 2012 Jun 21;366(25):2390-6
pubmed: 22716977
N Engl J Med. 2017 Sep 21;377(12):1177-1187
pubmed: 28930509
J Thromb Haemost. 2017 Apr;15(4):670-677
pubmed: 28075532

Auteurs

Akihiro Tsuji (A)

Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Toshiyuki Miyata (T)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Akihiro Sekine (A)

Graduate School of Medicine, Chiba University, Japan.

Reiko Neki (R)

Division of Counseling for Medical Genetics, National Cerebral and Cardiovascular Center, Japan.

Koichi Kokame (K)

Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Japan.

Tsutomu Tomita (T)

Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, Japan.

Yumi Kashima (Y)

Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Ryotaro Asano (R)

Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Jin Ueda (J)

Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Tatsuo Aoki (T)

Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Takeshi Ogo (T)

Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH